News

GE Healthcare has held the license to market, sell and distribute Hexvix since 2006. As per the deal, Photocure and GE Healthcare are eligible to get an upfront

The study, which enrolled 167 paediatric patients with GHD, demonstrated that LB03002, using LGLS’ proprietary delivery technology Biohydrix, maintained expected growth rates for patients continuously treated for 24

Following the move, Vectura will receive a payment of $5m. Novartis has presented new NVA237 Phase III data at the European Respiratory Society (ERS) congress. The Glow1 and

The results from the trial demonstrated that the treatment reduced allergic symptoms in patients’ eyes by up to 30% more than placebo. The trial which involved around 50

The funds will be used to finance the Sarcob project, which is aimed to improve the nutrition of the elderly and to prevent and treat sarcopenic obesity with

Two one-year studies of over 1,500 roflumilast-treated patients with severe COPD, chronic bronchitis and a history of exacerbations were conducted. Roflumilast treatment in patients who were frequent exacerbators

Topas Elastomer E-140 cyclic olefin copolymer (COC) elastomer is indicated for use in aqueous, acidic, dry, and low-alcohol (up to 15% alcohol) food-contact applications. Topas Elastomer E-140 is

The product which has been developed by Telstar for R-Pharm consists a pass-through lyophilizer with a fully automated loading and unloading system. The loading side operates in a

The new product is a fixed-dose combination (in both oral and IV forms) containing netupitant, a neurokinin-1 (NK1) receptor antagonist, and palonosetron. The agreement allows Helsinn to take